Cerecor Inc. received a notice of noncompliance from the Nasdaq Listing Qualifications Staff, as the company's market value of listed securities failed to meet the minimum $35 million for the previous 30 consecutive business days.

The clinical-stage biopharmaceutical company said it was also not in compliance with a rule requiring it to maintain a minimum required stockholders' equity of $2.5 million and another requiring net income from continuing operations in the latest fiscal year or in two of the last three fiscal years.

The company has a period of 180 calendar days, or until July 12, to regain compliance.